查詢結果分析
相關文獻
- Retinal Pigment Epithelial Tear after Intravitreous Triamcinolone Acetonide Injection for Fibrovascular Pigment Epithelial Detachment
- Intravitreal Bevacizumab Therapy for the Treatment of Choroidal Neovascularization Secondary to Angioid Streaks: A Case Report
- Intravitreal Injection Bevacizumab for Vogt-Koyanagi-Harada Disease Complicated with Macular Choroidal Neovasculization--A Case Report
- Intravitreal Bevacizumab Alone or in Combination with Posterior Subtenon Injection of Triamcinolone in Treating Neovascular Age-Related Macular Degeneration
- 急性挫傷性視網膜色素壞死--兩病例報告
- Indocyanine Green Angiographic Features in Idiopathic Subfoveal Choroidal Neovascularization
- 老年性黃斑部病變之境界不明脈絡膜新生血管的灌流變化
- 脈絡膜骨瘤--病例報告
- 循血綠眼底攝影指引雷射治療老年性黃斑部變性之中心窩外境界不明的脈絡膜新生血管
- 老年性視網膜黃斑部變性治療的新發展--經瞳孔熱療法
頁籤選單縮合
題名 | Retinal Pigment Epithelial Tear after Intravitreous Triamcinolone Acetonide Injection for Fibrovascular Pigment Epithelial Detachment=纖維血管性色素上皮細胞剝離病患之玻璃體內注射丙酮特安皮質醇發生視網膜色素上皮細胞撕裂 |
---|---|
作者 | 吳佩昌; 陳勇仁; 郭錫恭; Wu, Pei-chang; Chen, Yung-jen; Kuo, Hsi-kung; |
期刊 | 長庚醫誌 |
出版日期 | 20110500、20110600 |
卷期 | 34:3 2011.05-06[民100.05-06] |
頁次 | 頁320-325 |
分類號 | 416.746 |
語文 | eng |
關鍵詞 | 新生血管; 丙酮特安皮質醇; 老年性黃斑病變; 視網膜色素上皮細胞; 玻璃體內注射; Neovascularization; Triamcinolone acetonide; Age-related macular degeneration; Retinal pigment epithelial tear; Intravitreous injection; |
英文摘要 | A 78-year-old woman was diagnosed with fibrovascular pigment epithelial detachment (PED) associated with age-related macular degeneration (AMD) affecting both eyes. Due to decreased vision in her left eye (20/2000) and disease progression, the patient received 4 mg of triamcinolone acetonide (TA) by intravitreal injection into her left eye. There were no immediate post-injection complications in the left eye. However, one week later, a retinal pigment epithelial (RPE) tear, temporal-inferior to the fovea in the left eye, was noted and confirmed by fundus photography, fluorescein angiography and optical coherence tomography. In contrast, there no similar RPE tear occurred in her right eye after treated several times by intravitreous bevacizumab injection. Not only anti-vascular endothelium growth factor agents, but also intravitreal TA when used to treat AMD with PED, would seem to induce a RPE tear in the absence of previous or concurrent adjuvant therapy. Further investigations are required to confirm the mechanism by which the RPE tear occurs. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。